Pravastatin up-regulates transforming growth factor-β1 in THP-1 human macrophages: Effect on scavenger receptor class A expression

Biochemical and Biophysical Research Communications

Volumn 314, Issue 3, 2004, Pages 704-710

  Baccante, Giovanna ^a   Mincione, Gabriella ^a   Di Marcantonio, Maria Carmela ^a   Piccirelli, Alessandro ^a   Cuccurullo, Franco ^a   Porreca, Ettore ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Atherosclerosis; Macrophages; Scavenger receptor class A; Transforming growth factor 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIBODY; ENZYME INHIBITOR; IMMUNOGLOBULIN RECEPTOR; ISOPROTEIN; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PHORBOL 12 ACETATE 13 MYRISTATE; PRAVASTATIN; PROTEIN P42; PROTEIN P44; SCAVENGER RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIOSYNTHESIS; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSFECTION; GENETICS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOLOGY; MACROPHAGE; METABOLISM; NORTHERN BLOTTING; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; UPREGULATION; WESTERN BLOTTING;

EID: 1642497638     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.150     Document Type: Article

References (28)

1. Blobe G.C., Schiemann W.P., Lodish H.F. Role of transforming growth factor β in human disease. N. Engl. J. Med. 342:2000;1350-1358.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
3. Grainger D.J., Mosedale D.E., Metcalfe J.C., Bottinger E.P. Dietary fat and reduced levels of TGF-. β1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions J. Cell Sci. 113:2000;2355-2361.
4. Argmann C.A., Van Den Diepstraten C.H., Sawyez C.G., Edwards J.Y., Hegele R.A., Wolfe B.M., Huff M.W. Transforming growth factor-. β1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants Arterioscler. Thromb. Vasc. Biol. 21:2001;2011-2018.
5. Rosenson R.S., Tangney C.C., Casey L.C. Inhibition of proinflammatory cytokine production by pravastatin. Lancet. 353:1999;983-984.
6. Ferro D., Parrotto S., Basili S., Alessandri C., Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J. Am. Coll. Cardiol. 36:2000;427-431.
7. Kim S.I., Han D.C., Lee H.B. Lovastatin inhibits transforming growth factor-beta 1 expression in diabetic rat glomeruli and cultured rat mesangial cells. J. Am. Soc. Nephrol. 11:2000;80-87.
8. Park H.J., Galper J.B. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase. Proc. Natl. Acad. Sci. USA. 96:1999;11525-11530.
9. de Winther M.P., van Dijk K.W., Havekes L.M., Hofker M.H. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20:2000;290-297.
10. Bottalico L.A., Wager R.E., Agellon L.B., Assoian R.K., Tabas I. Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. J. Biol. Chem. 266:1991;22866-22871.
11. Nishimura N., Harada-Shiba M., Tajima S., Sugano R., Yamamura T., Qiang Q.Z., Yamamoto A. Acquisition of secretion of transforming growth factor-. β1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line, THP-1 J. Biol. Chem. 273:1998;1562-1567.
12. van Waarde M.A., van Assen A.J., Kampinga H.H., Konings A.W., Vujaskovic Z. Quantification of transforming growth factor-β in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 247:1997;45-51.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
14. Sakamoto H., Aikawa M., Hill C.C., Weiss D., Taylor W.R., Libby P., Lee R.T. Biomechanical strain induces class a scavenger receptor expression in human monocyte/macrophages and THP-1 cells: a potential mechanism of increased atherosclerosis in hypertension. Circulation. 104:2001;109-114.
15. Han J., Hajjar D.P., Tauras J.M., Feng J., Gotto A.M. Jr., Nicholson A.C. Transforming growth factor-. β1 (TGF- β1) and TGF- β2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma J. Biol. Chem. 275:2000;1241-1246.
16. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 391:1998;79-82.
17. Takemoto M., Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21:2001;1712-1719.
18. Sakai M., Kobori S., Matsumura T., Biwa T., Sato Y., Takemura T., Hakamata H., Horiuchi S., Shichiri M. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein. Atherosclerosis. 133:1997;51-59.
19. Aikawa M., Rabkin E., Sugiyama S., Voglic S.J., Fukumoto Y., Furukawa Y., Shiomi M., Schoen F.J., Libby P. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 103:2001;276-283.
20. Assoian R.K., Fleurdelys B.E., Stevenson H.C., Miller P.J., Madtes D.K., Raines E.W., Ross R., Sporn M.B. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA. 84:1997;6020-6024.
21. Bobik A., Agrotis A., Kanellakis P., Dilley R., Krushinsky A., Smirnov V., Tararak E., Condron M., Kostolias G. Distinct patterns of transforming growth factor-β isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation. 99:1999;2883-2891.
22. Porreca E., Di Febbo C., Baccante G., Di Nisio M., Cuccurullo F. Increased transforming growth factor-beta (1) circulating levels and production in human monocytes after 3-hydroxy-3methyl-glutaryl-coenzyme a reductase inhibition with pravastatin. J. Am. Coll. Cardiol. 39:2002;1752-1757.
23. Umetani N., Kanayama Y., Akamura M., Negoro N., Takeda T. Lovastatin inhibits gene expression of type-scavenger receptor in THP-1 human macrophages. Biochim. Biophys. Acta. 1303:1996;199-206.
24. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:1995;7686-7689.
25. Camp H.S., Tafuri S.R. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 272:1997;10811-10816.
26. Mulder K.M. Role of ras and mapks in TGF-β signaling. Cytokine Growth Factor Rev. 11:2000;23-35.
27. Grainger D.J., Kemp P.R., Metcalfe J.C., Liu A.C., Lawn R.M., Williams N.R., Grace A.A., Schofield P.M., Chauhan A. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat. Med. 1:1995;74-79.
28. Gough P.J., Greaves D.R., Suzuki H., Hakkinen T., Hiltunen M.O., Turunen M., Herttuala S.Y., Kodama T., Gordon S. Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 19:1999;461-471.